Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index
Conditions: Hematopoietic Stem Cell Transplant (HSCT); Endothelial Injury Intervention: Drug: Pravastatin Sponsor: Children's Hospital Medical Center, Cincinnati Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials